<DOC>
	<DOC>NCT02218021</DOC>
	<brief_summary>The purpose of this study is to evaluate the abuse potential and safety of samidorphan in healthy, non-dependent, adult, recreational opioid users.</brief_summary>
	<brief_title>A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users</brief_title>
	<detailed_description />
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Be in good general physical health Body mass index of 1834 kg/m2, inclusive with minimum weight of 50 kg Recreational opioid use experience for nontherapeutic purposes (at &gt;/= 10 times in lifetime and &gt;/= 1 in previous 3 months Agree to use an approved method of birth control for the duration of the study Additional criteria may apply Currently pregnant or breastfeeding History of or current infection with hepatitis B virus, hepatitis C virus or HIV Current or history of any clinically significant medical or psychiatric condition Current or history of in the last 2 years of dependence on alcohol or any illicit drugs Have used any prescription or overthecounter medication, including natural health products (with the exception of prescription birth control or hormonal replacements, acetaminophen, ibuprofen, or multivitamins) within 14 days Have a history of intolerance or hypersensitivity to opioid antagonists, opioid agonists or related drugs (eg, naltrexone, naloxone, oxycodone, morphine) Additional criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Alkermes</keyword>
	<keyword>ALKS 33</keyword>
	<keyword>ALKS 5461</keyword>
	<keyword>Samidorphan</keyword>
</DOC>